Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

NanoViricides Inc. (NNVC)

2.31   0.102 (4.64%) 11-19 15:47
Open: 2.2 Pre. Close: 2.2076
High: 2.4 Low: 2.15
Volume: 13,465 Market Cap: 9M
Nanoviricides Inc is a development stage nano-biopharmaceutical company. Its business activities are to discover, develop and commercialize therapeutics to take care of patients suffering from life-threatening viral infections.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.403 - 2.413 2.413 - 2.422
Low: 2.128 - 2.138 2.138 - 2.147
Close: 2.383 - 2.4 2.4 - 2.416

Technical analysis

as of: 2019-11-19 4:28:34 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.20     One year: 3.74
Support: Support1: 2.07    Support2: 1.65
Resistance: Resistance1: 2.74    Resistance2: 3.20
Pivot: 2.12
Moving Average: MA(5): 2.21     MA(20): 2.18
MA(100): 3.53     MA(250): 4.96
MACD: MACD(12,26): -0.06     Signal(9): -0.11
Stochastic oscillator: %K(14,3): 57.19     %D(3): 46.48
RSI: RSI(14): 55.09
52-week: High: 13.60  Low: 1.27  Change(%): -63.6
Average Vol(K): 3-Month: 4655  10-Days: 1307

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
NNVC has closed above the upper band by 9.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 57.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to NNVC's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

NanoViricides is Creating Nanomedicines to Develop Antiviral Therapies to Combat Shingles and Herpes Viruses Interviewing with Proactive Investors, President & Chairman Anil R. Diwan Outlines the History and Cutting Edge Technology Driving Proprietary Therapies
SHELTON, CT / ACCESSWIRE / October 3, 2019 / NanoViricides, Inc., (NYSE American:NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, based on the nanoviricides® platform, announces that Anil R. Diwan, PhD, President and Executive Chairman, was interviewed

NanoViricides, Inc. Announces One-for-Twenty Reverse Stock Split
SHELTON, Conn., Sept. 12, 2019 /PRNewswire/ -- NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), announced today that its Board of Directors has approved a 1-for-20 reverse split of all of the Company's capital stock, including its common stock, which will be effective after the market

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 3.84
Shares Float (M) 2.73
% Held by Insiders 28.05
% Held by Institutions 5.03
Shares Short (K) 11
Shares Short P. Month (K)

Stock Financials

EPS -2.400
Book Value (p.s.) 2.760
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -33.8
Return on Equity (ttm) -59.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.073
Qtrly Earnings Growth
Operating Cash Flow (M) -6.80
Levered Free Cash Flow (M) -2.32

Stock Valuations

P/E Growth Ratio 0.09
P/BV 0.87
P/CF -1.36

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-09-24
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.